Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Press Release Global Blood Therapeutics Announces Proposed Public Offering Of Common Stock is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Viking Therapeutics Announces Proposed Public Offering of Common Stock
SAN DIEGO, Feb. 27, 2024 /PRNewswire/ -- Viking Therapeutics ... today announced that it has commenced an underwritten public offering of $350.0 million of shares of its common stock. Read More
Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX) today announced the closing of its previously announced underwritten public offering ... Read More
Revance Announces Proposed Public Offering of Common Stock
March 04, 2024--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC) ("Revance" or the "Company") today announced a proposed underwritten public offering of $100 million of its common stock. Read More
Cognition Therapeutics Announces Proposed Public Offering of Common Stock
March 11, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics ... today announced that it has commenced an underwritten public offering (the “offering”) of shares of its common stock. Read More
Janux Therapeutics Announces Proposed Public Offering of Common Stock
SAN DIEGO--(BUSINESS WIRE)-- Janux Therapeutics ... today announced that it has commenced an underwritten public offering of $175.0 million of shares of its common stock. In addition, Janux ... Read More
Aquestive Therapeutics Announces Proposed Public Offering of Common Stock
WARREN, N.J., March 19, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics ... today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Read More
Aquestive Therapeutics Announces Proposed Public Offering of Common Stock
WARREN, N.J., March 19, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics ... and delivery technologies, today announced that it intends to offer and sell shares of its common stock in an underwritten ... Read More
Viking Therapeutics Announces Proposed Public Offering of Common Stock
SAN DIEGO, Feb. 27, 2024 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus